MRNA Stock Down on Updates for 2025 - Yahoo Finance

Jan 16, 2025 · MRNA Stock Down on Updates for 2025 Moderna provides updates on its business and pipeline progress at the J.P. Morgan Healthcare Conference. Moderna reported …

CouponFollow Extension

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

Jan 14, 2025 · At the J.P. Morgan Healthcare Conference, Moderna MRNA announced several financial updates on its business and updates on its pipeline progress. Moderna reported …

yahoo.com

28%
OFF

Is Moderna A Bad-News Buy For 2025? - The Motley Fool

2 weeks from now

Jan 16, 2025 · Moderna (MRNA-7.28%) ... This helped the stock to skyrocket, reaching a high of more than $480 at its peak in 2021. ... down from a September forecast of $2.5 billion to $3.5 …

fool.com

51%
OFF

Is Moderna Stock A No-Brainer Buy On The Sell-Off?

2 weeks from now

Jan 15, 2025 · A bad seven-month stretch just got worse for Moderna (MRNA-6.51%).The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan …

fool.com

98%
OFF

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why

2 weeks from now

Moderna (MRNA) closed at $34.45 in the latest trading session, marking a -1.98% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.12%. Meanwhile, …

yahoo.com

17%
OFF

Watch These Moderna Price Levels As Stock Plummets After …

2 weeks from now

Jan 14, 2025 · Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these …

investopedia.com

8%
OFF

Moderna, Inc. (MRNA) Latest Stock News & Headlines - Yahoo …

2 weeks from now

The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key earnings and labor market data. Let us look at some biotech …

yahoo.com

7%
OFF

Moderna (MRNA) Stock Jumps 11.7%: Will It Continue To Soar?

2 weeks from now

Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength …

yahoo.com

21%
OFF

3 Top AI-Powered Biotech Stocks To Buy In February

2 weeks from now

2 days ago · Management expects continued operating and financial momentum, targeting 2025 adjusted earnings per share (EPS) between $12.12 and $12.32, representing a solid 21% …

fool.com

5%
OFF

Amazon Earnings Recap: Stock Dips On Guidance, Capex Plans

2 weeks from now

1 day ago · Amazon's Q4 earnings beat analyst expectations, but AMZN stock sunk over 5% after hours. The call's discussion focused on AI spending and AWS growth.

businessinsider.com

FAQs about MRNA Stock Down on Updates for 2025 - Yahoo Finance Coupon?

Why did Moderna (mRNA) stock drop this week?

Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna (NASDAQ: MRNA). The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin. ...

Is Moderna (mRNA) a good stock to buy in 2024?

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. ...

How many product approvals will Moderna (mRNA) get?

However, Moderna still expects 10 product approvals over the next three years that could fuel growth. A bad seven-month stretch just got worse for Moderna (MRNA -1.96%). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday. ...

Will Moderna (mRNA) deliver a year-over-year decline in earnings?

Moderna (MRNA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. ...

Is Moderna a good stock to buy in 2025?

If we assume Moderna only hits the low end of its 2025 revenue forecast, the stock trades at roughly 9 times forward sales. That's well above the 7.2 price-to-sales ratio for the biotech industry. However, Moderna's enterprise value (EV) is $10.75 billion -- lower than its market cap thanks to a hefty cash stockpile and manageable debt load. ...

Will Moderna stock continue to slash its 2025 revenue forecast?

Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. The stock broke down from a two-month pennant pattern, setting the stage for a potential continuation move lower. ...